论文部分内容阅读
肝细胞癌(HCC)是常见恶性肿瘤之一,手术和肝移植是目前可治愈的手段,但是术后易复发,预后较差。微血管侵犯是(MVI)独立的预后因素,其术前诊断成为研究的热点。笔者就目前的术前预测HCC并微MVI的研究进展进行综述。
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. Surgical and liver transplantation are currently the most feasible means of treatment, but recurrence after surgery is very poor prognosis. Microvascular invasion (MVI) is an independent prognostic factor, and its preoperative diagnosis has become a hot research topic. The author summarizes the current progress of HCC prediction and micro-MVI.